EMS Providers' Health Initiative Study
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aims to explore dietary factors that influence glycemic control in night shift EMS providers and to test the feasibility of a dietary intervention among these providers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2021
CompletedFirst Posted
Study publicly available on registry
December 10, 2021
CompletedStudy Start
First participant enrolled
June 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 27, 2026
January 1, 2026
4.5 years
November 29, 2021
January 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Glycemic control
Daily mean blood glucose
Two weeks
Compliance
Percent of participants who adhere to the dietary intervention
Four days
Secondary Outcomes (1)
Perceived stress
Two weeks
Study Arms (2)
High protein
ACTIVE COMPARATORConsuming a meal composed of 2:1 grams of protein to carbohydrate during the night shift between 7pm-7am
Moderate protein
PLACEBO COMPARATORConsuming a meal composed of 1:1 grams of protein to carbohydrate during the night shift between 7pm-7am
Interventions
The primary goal is to pilot the feasibility of a meal service intervention in night shift workers
Eligibility Criteria
You may qualify if:
- Emergency medical service (EMS) provider
- Works night shift only for at least one year
- Provides patient care as primary duty
You may not qualify if:
- Diagnosis of a metabolic disease (i.e. diabetes, prediabetes, metabolic syndrome)
- Taking medication to lower blood glucose
- Pregnant or planning to become pregnant
- Diagnosis of kidney disease or impairment
- Allergies or intolerances to study foods
- Digestive disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University at Buffalo
Buffalo, New York, 14214, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
David Hostler, PhD
University at Buffalo
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral Associate
Study Record Dates
First Submitted
November 29, 2021
First Posted
December 10, 2021
Study Start
June 7, 2022
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 27, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
IPD will be de-identified and kept in a password protected database (REDcap.com)